Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-03-17
1994-05-24
Fay, Zohreh
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514419, 514513, 514568, 514912, A61K 3140, A61K 3121, A61K 3119
Patent
active
053149092
ABSTRACT:
Topically applied non-steroidal antiinflammatory agents (NSAID's) are useful in the treatment of macular degeneration.
REFERENCES:
patent: 4087538 (1978-05-01), Portnoff
Medline Abstract of Graefes Arch Clin Exp Ophthalmol 1992, 230(5) pp. 401-405, Peterson et al.
Medline Abstract of Klin Oczna, Jan. 1993, 95(1) pp. 44-46, Kaliska et al.
Ayler Sylvia A.
Daniel Mark R.
DiPrima Joseph F.
Fay Zohreh
Merck & Co. , Inc.
LandOfFree
Use of non-steroidal antiiflammatory agents in macular degenerat does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of non-steroidal antiiflammatory agents in macular degenerat, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of non-steroidal antiiflammatory agents in macular degenerat will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1973025